Bailey, who is director for the Center for Health Systems Improvement at UTHSC, which receives 25,000 visits annually, says their survey data showed that “less than 25% of low-income people had one or more primary care visits in 2020.” So, the intersection of having a low income, living in a community of color and having… Read More
Students at Rhodes College who haven’t had their COVID-19 vaccine will likely have to pay a $1,500 fee each semester starting this fall. The charge will begin once the FDA fully approves the COVID-19 vaccine, which Rhodes expects to happen this summer. Right now, the vaccine is only authorized for emergency use.
In early 2020, when the novel coronavirus was gaining momentum but had not yet been named a pandemic, computational chemist Marti Head of Oak Ridge National Laboratory – along with scientists and researchers around the globe – abruptly switched her focus to the fight against COVID-19.
According to a report ‘Healthy profession, healthy patients: The state of clinical nutrition in Pakistan’ published by The Economist Intelligence Unit, over 37 per cent of the households in the country suffer from food insecurities, leading to malnutrition among all age groups, but particularly affecting the infants and adolescents at large. June 11: Pakistan Point
The COVID-19 pandemic challenged all of us, but hope is on the horizon. With vaccinations on the rise and case counts dropping, we’ve reached a turning point in the fight against COVID-19. But our patients, our community, our nation, and the world need your help.
Doctors Brian Fowler and Salar Rafieetary talk about the Cataract-a-thon, an event that will provide free surgeries to participates thanks to the UTHSC Hamilton Eye Institute.
Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology, today announced results from a Cellworks Clinical Trial, in which the Cellworks Computational Omics Biology Model (CBM) accurately predicted that All-Trans Retinoic Acid (ATRA) combined with cytarabine, etoposide, idarubicin (ATRA-CEI) benefits a subset of non-APL (Acute Promyelocytic… Read More
East Tennessee State University’s Center for Cardiovascular Risks Research is collaborating with researchers from the University of Tennessee Health Science Center and other key academic partners across the state to create a statewide network to identify, develop and implement patient-centered approaches to improve quality of care and outcomes for people with cardiovascular disease. June 3:… Read More
